QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SCIENTURE HOLDINGS, INC. ( SCNX), a holding company for existing and planned pharmaceutical operating companies focused on prov...

Core News & Articles

-SEC Filing

Core News & Articles

SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused o...

Core News & Articles

Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.48) per share. This is a 58.62 percent increase over losses o...

Core News & Articles

-SEC Filing

Core News & Articles

Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company") a holding company...

Core News & Articles

SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company"), a holding company for existing and planned pharmaceutical opera...

Core News & Articles

SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused o...

Core News & Articles

AMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) a holding company for existing and planned ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION